To screen for recurrence or metastatic disease in patients with stage IIB-IV melanoma, the National Comprehensive Cancer Network (NCCN) guidelines recommend a comprehensive history and physical every 3-12 months for 2 years, then every 6-12 months for another 3 years and annually thereafter as indicated. Surveillance imaging may also be considered every 3-12 months for 2 years as well at the discretion of the physician, per the same guidelines. Further, routine imaging to screen for asymptomatic recurrence or metastatic disease is not indicated after 3-5 years because most recurrences occur within the first 3 years.
Learn more about patient follow-up in metastatic melanoma.
Medscape © 2023 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Adil Daud. Fast Five Quiz: Metastatic Melanoma - Medscape - Mar 15, 2023.
Comments